Radioiodine (131-I) treatment for Graves’ disease: Geant4 Monte Carlo simulation for patient personalized dose estimation

Authors

  • A. Ben-Ismail National Center for Nuclear Sciences and Technology, Ariana, Tunisia
  • S. Elj National Center for Nuclear Sciences and Technology, Ariana, Tunisia
  • S. Meftah Laboratory of Biophysics and Medical Technologies of Tunis, Tunis, Tunisia
  • T. Kraïem National Radiation Protection Center of Tunis, Tunis, Tunisia
Abstract:

Background: Reliable estimation of radiation-absorbed dose is necessary to evaluate the benefits and the risks of radiopharmaceuticals used for diagnostic or therapeutic purposes in nuclear medicine. Materiel and Methods: This study included 47 patients treated with iodine-131 for Graves’ disease. A comparative study between Geant4 Monte Carlo simulation and MIRD formalism was carried out to evaluate the dose received by each patient. Patients’ thyroids and internal radiation were modeled using Geant4. Geant4 simulations were compared to experimental measurements performed with TLDs placed inside an ellipsoidal Thyroid phantom. MIRD was used to determine the beta doses received by the different patients. Results: The average difference between MIRD and Geant4 considering only beta emitted radiation was approximately 5.6%; this difference is justified by the fact that, Geant4, contrary to MIRD, considers all particle energies of the 131I spectrum, the shape of the thyroid and the heterogeneity of the dose deposited in the modeled volume. A good agreement was found between experiment and Geant4 simulations. The total dose received by patients varies between 176Gy and 359Gy. After 9 month, 74% of treated patients were rendered hypothyroid. Conclusion: This study showed the necessity of determining the specific activity of each patient considering the thyroid volume and the iodine fixation. It also revealed that the Geant4 toolis appropriate for accurate internal dosimetry calculations, particularly for the case of Graves’ disease treatment. GEANT4 can be used as a standard for the comparison of experimental measurements.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

Single dose planning for radioiodine-131 therapy of Graves' disease.

OBJECTIVE Patients with Graves' disease were studied one year after radioiodine-131 therapy to assess the relationship between the effectiveness of the therapy and the radioiodine doses used. METHODS Patients were classified into three groups according to thyroid function as hyperthyroidism, euthyroidism and hypothyroidism at one year after I-131 therapy. In these groups we compared the mean ...

full text

Radioiodine I-131 for the therapy of graves' disease.

Graves' disease is a common cause of hyperthyroidism. Treatment options for Graves' disease include antithyroid medication, surgery or radioactive iodine (I-31) or RAI. This review will focus on the approach to RAI therapy; discussing dose selection, patient preparation, and consideration before and after administering RAI, examining aspects of pre-treatment with antithyroid medication as well ...

full text

Thorax organ dose estimation in computed tomography based on patient CT data using Monte Carlo simulation

Background:  This study presents patient specific and organ dose estimation in computed tomography (CT) imaging of thorax directly from patient CT image using Monte Carlo simulation.  Patient's CT image is considered as the patient specific phantom and the best representative of patient physical index in order to calculate specific organ dose. Materials and Methods: EGSnrc /BEAMnr...

full text

A GEANT4 Monte-Carlo Simulation Code for precision β spectroscopy

The measurement of the β asymmetry parameter in nuclear β decay is a potentially very sensitive tool to search for non V −A components in the charge-changing weak interaction. To reach the required precision (percent level) all effects that modify the emission pattern of the β radiation, i.e. the geometry of the setup, the effect of the magnetic field on the trajectories of β particles as well ...

full text

Graves' ophthalmopathy in patients treated with radioiodine 131-I.

BACKGROUND Radioiodine treatment of hyperthyroidism in Graves' disease patients may cause or aggravate the course of ophthalmopathy (GO). We evaluated the activity and severity of ophthalmopathy in patients who acquired GO following radioiodine therapy. MATERIAL AND METHODS Between 2003 and 2005, 763 Graves' disease patients (50.9% of the total number of 1,500 patients referred to our Departm...

full text

Radioiodine treatment of Graves' disease - dose/response analysis.

The clinical outcome of 153 Graves' disease patients treated with a wide dose range of radioactive iodine-131 (RAI) was analyzed retrospectively. Six to nine months after the first dose of RAI 60 patients (39%) were hypothyroid (or rather thyroxine-substituted) and 26 (17%) were euthyroid, while 67 patients (44%) did not respond properly: in 32 (21%) their antithyroid drug (ATD) dose could be r...

full text

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume 19  issue 1

pages  213- 221

publication date 2021-01

By following a journal you will be notified via email when a new issue of this journal is published.

Keywords

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023